Tag Archives: FDA

Concentrics Research conducts pivotal studies for novel FDA OTC Naloxone labeling – work cited as unprecedented by FDA Commissioner

Posted January 18th, 2019. Filed under Concentrics News
Tags: , ,

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm629571.htm